Evaluation of 1-methyl-2-(4'-fluorophenyl)-5-nitroimidazole.
D000005:Abdomen; D000563:Amebicides / Q000627:therapeutic use*; D001786:Blood Glucose; D001792:Blood Platelets; D004404:Dysentery, Amebic / Q000188:drug therapy*; D004562:Electrocardiography; D004748:Entamoeba histolytica; D005260:Female; D005461:Fluorine / Q000627:therapeutic use; D006454:Hemoglobins; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D009325:Nausea / Q000139:chemically induced; D009574:Nitro Compounds / Q000627:therapeutic use; D010146:Pain; D014839:Vomiting / Q000139:chemically induced
D000563:Amebicides; D001786:Blood Glucose; D006454:Hemoglobins; D007093:Imidazoles; D009574:Nitro Compounds; D005461:Fluorine